Accrol Group Holdings plc Board Changes

Accrol Group Holdings plc
[shareaholic app="share_buttons" id_name="post_below_content"]

Accrol Group Holdings plc (LON: ACRL) announced today that Steve Townsley has today stepped down from the Board and his role as Chief Financial Officer for health reasons.

Hannah Argo, who joined the Group on 10 January 2019, has been appointed as Interim CFO. Hannah has extensive experience in senior financial roles gained with a number of global Blue Chip FMCG and Pharma businesses, including Alliance Boots, Robert McBride and latterly Tulip UK.

Dan Wright, Chairman of Accrol Group Holdings plc, said:

“Hannah is a proven and dynamic CFO with excellent communication and motivational skills. She is a strategic thinker, who is equally at home with the operational details. Her all-round business knowledge and a strong commercial focus are well suited to the Group’s current needs. I look forward to working with her and extend a warm welcome to the Group.

“On behalf of the Board, I thank Steve for the short but important role he has played in the turnaround of the Group. We wish him well.”

The Board now comprises, Dan Wright (Executive Chairman), Gareth Jenkins (Chief Executive Officer), Euan Hamilton (Non-Executive), & Simon Allport (Non-Executive) and plans to commence a process to find a new permanent Chief Financial Officer in due course.

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
Accrol Group Holdings plc (LON:ACRL) has announced the publication of a shareholder circular detailing terms of the Scheme. Learn more here.
Discover the latest results and overview of Accrol Group Holdings, the UK's top independent tissue converter, led by CEO Gareth Jenkins and CFO Chris Welsh.
In this interview, Gervais Williams, co-fund manager of Miton UK MicroCap Trust, discusses navigating the economic landscape and standout companies in 2024. Find out more here. #investment #microcap
Accrol Group Holdings plc has reported strong H1 FY24 results, with impressive growth in adjusted EBITDA and adjusted PBT. The company remains on track to meet expectations and has seen gains in market share. Furthermore, the private label segment of the UK tissue market continues to increase, and the sales of biodegradable wet wipes have been exceptionally strong. Accrol's outlook remains positive with expected further volume growth.
Accrol Group Holdings plc has reported strong performance in H1 FY24, with branded volumes rising by 45% and margins returning to pre-pandemic levels. The group is on track to deliver FY24 results in line with expectations and expects to outperform previous expectations for FY25.

Search

Search